Detalles de la búsqueda
1.
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
Br J Haematol
; 204(1): 250-259, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37784256
2.
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
Acta Oncol
; 61(11): 1332-1338, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214787
3.
Saprochaete clavata Outbreak Infecting Cancer Center through Dishwasher.
Emerg Infect Dis
; 26(9): 2031-2038, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32818391
4.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Biol Blood Marrow Transplant
; 26(12): 2299-2305, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822845
5.
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.
Blood
; 132(7): 750-754, 2018 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29760162
6.
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.
BMC Cancer
; 20(1): 1140, 2020 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234127
7.
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1810-1817, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128326
8.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128325
9.
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.
Blood
; 129(5): 643-649, 2017 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27899357
10.
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Transfusion
; 59(11): 3442-3447, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625183
11.
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(3): 549-554, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247781
12.
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Biol Blood Marrow Transplant
; 24(3): 627-632, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29197681
13.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29448057
14.
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 23(9): 1549-1554, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28499937
15.
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.
Br J Haematol
; 179(5): 790-801, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29048109
16.
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia.
Haematologica
; 102(1): 184-191, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27561720
17.
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Biol Blood Marrow Transplant
; 22(1): 119-24, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341397
18.
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
Biol Blood Marrow Transplant
; 21(3): 445-53, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25460357
19.
Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: results of a multicenter prospective phase 2 trial.
Cancer
; 121(4): 562-9, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25283774
20.
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
Cancer
; 121(11): 1809-16, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25649994